Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and dopamine β-hydroxylase

Biological Psychiatry

Volumn 73, Issue 3, 2013, Pages 219-224

  Kosten, Thomas R ^a   Wu, Guiying ^a   Huang, Wen ^a   Harding, Mark J ^a   Hamon, Sara C ^b   Lappalainen, Jaakko ^c   Nielsen, David A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cocaine; dependence; disulfiram; genes; polymorphism; treatment

Indexed keywords

DISULFIRAM; METHADONE; PLACEBO;

ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; DNA POLYMORPHISM; DOPAMINE BETA MONOOXYGENASE GENE; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GENE; GENE FUNCTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PHARMACOGENETICS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SEXUALITY; SIDE EFFECT; SUICIDE ATTEMPT; TREATMENT OUTCOME; URINALYSIS;

ADULT; COCAINE-RELATED DISORDERS; DISULFIRAM; DOPAMINE BETA-HYDROXYLASE; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HUMANS; MALE; METHADONE; MIDDLE AGED; OPIOID-RELATED DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; TREATMENT OUTCOME;

EID: 84872677680     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.07.011     Document Type: Article

References (77)

1. A.T. McLellan, D.C. Lewis, C.P. O'Brien, and H.D. Kleber Drug dependence, a chronic medical illness: Implications for treatment, insurance, and outcomes evaluation JAMA 284 2000 1689 1695
2. SAMHSA Results from the 2010 National Survey on Drug Use and Health (NSDUH). H-41 NS 2011 Substance Abuse and Mental Health Services Administration Rockville, MD
3. B.C. Wolf, W.A. Lavezzi, L.M. Sullivan, and L.M. Flannagan Methadone-related deaths in Palm Beach County J Forensic Sci 49 2004 375 378
4. D.A. Bux, R.J. Lamb, and M.Y. Iguchi Cocaine use and HIV risk behavior in methadone maintenance patients Drug Alcohol Depend 37 1995 29 35
5. R.J. MacGowan, R.R. Fichtner, N. Swanson, C. Collier, A. Kroliczak, and G. Cole Factors associated with client-reported HIV infection among clients entering methadone treatment AIDS Educ Prev 9 1997 205 217
6. B. Meandzija, P.G. O'Connor, B. Fitzgerald, B.J. Rounsaville, and T.R. Kosten HIV infection and cocaine use in methadone maintained and untreated intravenous drug users Drug Alcohol Depend 36 1994 109 113
7. D.M. Hartel, E.E. Schoenbaum, P.A. Selwyn, J. Kline, K. Davenny, and R.S. Klein Heroin use during methadone maintenance treatment: The importance of methadone dose and cocaine use Am J Public Health 85 1995 83 88
8. G. Bovasso, and J. Cacciola The long-term outcomes of drug use by methadone maintenance patients J Behav Health Serv Res 30 2003 290 303
9. T.R. Kosten, B.J. Rounsaville, and H.D. Kleber Antecedents and consequences of cocaine abuse among opioid addicts A 2.5-year follow-up J Nerv Ment Dis 176 1988 176 181
10. S. Magura, A. Rosenblum, and E.M. Rodriguez Changes in HIV risk behaviors among cocaine-using methadone patients J Addict Dis 17 1998 71 90
11. S. Magura, A. Rosenblum, C. Fong, C. Villano, and B. Richman Treating cocaine-using methadone patients: Predictors of outcomes in a psychosocial clinical trial Subst Use Misuse 37 2002 1927 1955
12. J.L. Black, M.P. Dolan, W.E. Penk, R. Robinowitz, and H.A. DeFord The effect of increased cocaine use on drug treatment Addict Behav 12 1987 289 292
13. G.H. Dunteman, W.S. Condelli, and J.A. Fairbank Predicting cocaine use among methadone patients: Analysis of findings from a national study Hosp Community Psychiatry 43 1992 608 611
14. M.S. Lima, A.A. Reisser, B.G. Soares, and M. Farrell Antidepressants for cocaine dependence Cochrane Database Syst Rev 2003 CD002950
15. L. Amato, S. Minozzi, P.P. Pani, R. Solimini, S. Vecchi, P. Zuccaro, and M. Davoli Dopamine agonists for the treatment of cocaine dependence Cochrane Database Sys Rev 2011 CD003352
16. A.R. Lima, M.S. Lima, B.G. Soares, and M. Farrell Carbamazepine for cocaine dependence Cochrane Database Syst Rev 2002 CD002023
17. K.M. Carroll, L.R. Fenton, S.A. Ball, C. Nich, T.L. Frankforter, and J. Shi Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: A randomized placebo-controlled trial Arch Gen Psychiatry 61 2004 264 272
18. K.M. Carroll, C. Nich, S.A. Ball, E. McCance, and B.J. Rounsavile Treatment of cocaine and alcohol dependence with psychotherapy and disulfiram Addiction 93 1998 713 727
19. K.M. Carroll Psychotherapeutic treatment of cocaine abuse: Models for its evaluation alone and in combination with pharmacotherapy NIDA Res Monogr 135 1993 116 132
20. T.P. George, M.C. Chawarski, J. Pakes, K.M. Carroll, T.R. Kosten, and R.S. Schottenfeld Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: A preliminary trial Biol Psychiatry 47 2000 1080 1086
21. I.L. Petrakis, K.M. Carroll, C. Nich, L.T. Gordon, E.F. McCance-Katz, and T. Frankforter Disulfiram treatment for cocaine dependence in methadone-maintained opioid addicts Addiction 95 2000 219 228
22. G. Laje, and F.J. McMahon The pharmacogenetics of major depression: Past, present, and future Biol Psychiatry 62 2007 1205 1207
23. G.M. Murphy Jr, C. Kremer, H.E. Rodrigues, and A.F. Schatzberg Pharmacogenetics of antidepressant medication intolerance Am J Psychiatry 160 2003 1830 1835
24. A.K. Malhotra, G.M. Murphy Jr, and J.L. Kennedy Pharmacogenetics of psychotropic drug response Am J Psychiatry 161 2004 780 796
25. J. deLeon, S.C. Armstrong, and K.L. Cozza Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 and CYP450 2C19 Psychosomatics 47 2006 75 85
26. J.F. Rogers, A.N. Nafziger, and J.S.J. Bertino Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs Am J Med 113 2002 746 750
27. D. Goldman, G. Oroszi, and F. Ducci The genetics of addictions: Uncovering the genes Nat Rev Genet 6 2005 521 532
28. A.I. Leshner Addiction is a brain disease, and it matters Science 278 1997 45 47
29. C. Weisner, H. Matzger, and L.A. Kaskutas How important is treatment? One-year outcomes of treated and untreated alcohol-dependent individuals Addiction 98 2003 901 911
30. D.D. Simpson, G.W. Joe, and K.M. Broome A national 5-year follow-up of treatment outcomes for cocaine dependence Arch Gen Psychiatry 59 2002 538 565
31. M. Sofuoglu, and T.R. Kosten Emerging pharmacological strategies in the fight against cocaine addiction Expert Opin Investig Drugs 11 2006 91 98
32. A. Vaccari, P.L. Saba, S. Ruiu, M. Collu, and P. Devoto Disulfiram and diethyldithiocarbamate intoxication affects the storage and release of striatal dopamine Toxicol Appl Pharmacol 139 1996 102 108
33. B.N. Bourdelat-Parks, G.M. Anderson, Z.R. Donaldson, J.M. Weiss, R.W. Bonsall, and M.S. Emery Effects of dopamine beta-hydroxylase genotype and disulfiram inhibition on catecholamine homeostasis in mice Psychopharmacology (Berl) 183 2005 72 80
34. J.R. Schank, R. Ventura, S. Puglisi-Allegra, A. Alcaro, C.D. Cole, and L.C. Liles Dopamine beta-hydroxylase knockout mice have alterations in dopamine signaling and are hypersensitive to cocaine Neuropsychopharmacology 31 2006 2221 2230
35. S.B. Ross, L. Wetterberg, and M. Myrhed Genetic control of plasma dopamine-beta-hydroxylase Life Sci 12 1973 529 532
36. R.M. Weinshilboum, F.A. Raymond, L.R. Elveback, and W.H. Weidman Serum dopamine-beta-hydroxylase activity: Sibling-sibling correlation Science 181 1973 943 945
37. G. Oxenstierna, G. Edman, L. Iselius, L. Oreland, S.B. Ross, and G. Sedvall Concentrations of monoamine metabolites in the cerebrospinal fluid of twins and unrelated individuals - a genetic study J Psychiatr Res 20 1986 19 29
38. J. Wei, C.N. Ramchand, and G.P. Hemmings Possible control of dopamine beta-hydroxylase via a codominant mechanism associated with the polymorphic (GT)n repeat at its gene locus in healthy individuals Hum Genet 99 1997 52 55
39. J.F. Cubells, H.R. Kranzler, E. McCance-Katz, G.M. Anderson, R.T. Malison, and L.H. Price A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia Mol Psychiatry 5 2000 56 63
40. J.F. Cubells, D.P. van Kammen, M.E. Kelley, G.M. Anderson, D.T. O'Connor, and L.H. Price Dopamine beta-hydroxylase: two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation Hum Genet 102 1998 533 540
41. C.P. Zabetian, G.M. Anderson, S.G. Buxbaum, R.C. Elston, H. Ichinose, and T. Nagatsu A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus Am J Hum Genet 68 2001 515 522
42. C.P. Zabetian, S.G. Buxbaum, R.C. Elston, M.D. Kohnke, G.M. Anderson, and J. Gelernter The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine beta-hydroxylase activity Am J Genet 72 2003 1389 1400
43. M.D. Kohnke, C.P. Zabetian, G.M. Anderson, W. Kolb, I. Gaertner, and G. Buchkremer A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function Biol Psychiatry 52 2002 1151 1158
44. N. Bhaduri, and K. Mukhopadhyay Correlation of plasma dopamine beta-hydroxylase activity with polymorphisms in DBH gene: A study on eastern Indian populaion Cell Mol Neurobiol 28 2008 343 350
45. J. Deinum, G.C. Steenbergen-Spanjers, M. Jansen, F. Boomsma, J.W. Lenders, and F.J. van Ittersum DBH gene variants that cause low plasma dopamine beta hydroxylase with or without a severe orthostatic syndrome J Med Genet 41 2004 e38
46. J. Wei, C.N. Ramchand, and G.P. Hemmings TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia Psychiatr Genet 8 1998 19 24
47. G.A. Rogeness, J.M. Hernandez, C.A. Macedo, S.A. Amrung, and S.K. Hoppe Near-zero plasma dopamine-beta-hydroxylase and conduct disorder in emotionally disturbed boys J Am Acad Child Psychiatry 25 1986 521 527
48. G.A. Rogeness, J.M. Hernandez, C.A. Macedo, E.L. Mitchell, S.A. Amrung, and W.R. Harris Clinical characteristics of emotionally disturbed boys with very low activities of dopamine-beta-hydroxylase J Am Acad Child Psychiatry 23 1984 203 208
49. G.A. Rogeness, M.A. Javors, J.W. Maas, C.A. Macedo, and C. Fischer Plasma dopamine-beta-hydroxylase, HVA, MHPG, and conduct disorder in emotionally disturbed boys Biol Psychiatry 22 1987 1158 1162
50. G.A. Rogeness, J.W. Maas, M.A. Javors, C.A. Macedo, W.R. Harris, and S.K. Hoppe Diagnoses, catecholamine metabolism, and plasma dopamine-beta-hydroxylase J Am Acad Child Adolesc Psychiatry 27 1988 121 125
51. M. Galvin, A. Shekhar, J. Simon, B. Stilwell, R. Ten Eyck, and G. Laite Low dopamine-beta-hydroxylase: A biological sequela of abuse and neglect? Psychiatry Res 39 1991 1 11
52. E.G. Jonsson, J. Bah, J. Melke, R. Abou Jamra, J. Schumacher, and L. Westberg Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers BMC Psychiatry 4 2004 4
53. A.T. McLellan, L. Luborsky, G.E. Woody, and C.P. O'Brien An improved diagnostic evaluation instrument for substance abuse patients The Addiction Severity Index J Nerv Ment Dis 168 1980 26 33
54. K.M. Carroll Manual-guided psychosocial treatment A new virtual requirement for pharmacotherapy trials? Arch Gen Psychiatry 54 1997 923 928
55. T. Plaseski, P. Noveski, S. Trivodalieva, G.D. Efremov, and D. Plaseska-Karanfilska Quantitative fluorescent-PCR detection of sex chromosome aneuploidies and AZF deletions/duplications Genet Test 12 2008 595 605
56. R Development Core Team R: A Language and Environment for Statistical Computing 2.9.1 ed. 2009 R Foundation for Statistical Computing Vienna, Austria
57. O. Lao, K. van Duijn, P. Kersbergen, P. de Knijff, and M. Kayser Proportioning whole-genome single-nucleotide-polymorphism diversity for the identification of geographic population structure and genetic ancestry Am J Hum Genet 78 2006 680 690
58. J.K. Pritchard, M. Stephens, and P. Donnelly Inference of population structure using multilocus genotype data Genetics 155 2000 945 959
59. M.J. Hubisz, D. Falush, M. Stephens, and J.K. Pritchard Inferring weak population structure with the assistance of sample group information Mol Ecol Resour 9 2009 1322 1332
60. P. Seeman, D. Weinshenker, R. Quirion, L.K. Srivastava, S.K. Bhardwaj, and D.K. Grandy Dopamine supersensitivity correlates with D2High states, implying many paths to psychosis Proc Natl Acad Sci U S A 102 2005 3513 3518
61. D. Weinshenker, and J.P. Schroeder There and back again: A tale of norepinephrine and drug addiction Neuropsychopharmacology 32 2007 1433 1451
62. D. Weinshenker, N.S. Miller, K. Blizinsky, M.L. Laughlin, and R.D. Palmiter Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals Proc Natl Acad Sci U S A 99 2002 13873 13877
63. J.R. Baker, P. Jatlow, and E.F. McCance-Katz Disulfiram effects on responses to intravenous cocaine administration Drug Alcohol Depend 87 2007 202 209
64. F.A. Hameedi, M.I. Rosen, E.F. McCance -Kat z, T.J. McMahon, L.H. Price, and P.I. Jatlow Behavioral, physiological, and pharmacological interaction of cocaine and disulfiram in humans Biol Psychiatry 37 1995 560 563
65. E.F. McCance-Katz, T.R. Kosten, and P. Jatlow Disulfiram effects on acute cocaine administration Drug Alcohol Depend 52 1998 27 39
66. E.F. McCance-Katz, T.R. Kosten, and P. Jatlow Chronic disulfiram treatment effects on intranasal cocaine administration: Initial results Biol Psychiatry 43 1998 540 543
67. J.F. Cubells, and C.P. Zabetian Human genetics of plasma dopamine beta-hydroxylase activity: Applications to research in psychiatry and neurology Psychopharmacology (Berl) 174 2004 463 476
68. H.Y. Meltzer, H.W. Cho, B.J. Carroll, and P. Russo Serum dopamine-beta-hydroxylase activity in the affective psychoses and schizophrenia Decreased activity in unipolar psychotically depressed patients Arch Gen Psychiatry 33 1976 585 591
69. L. Mod, Z. Rihmer, I. Magyar, M. Arato, A. Alfoldi, and G. Bagdy Serum DBH activity in psychotic vs. nonpsychotic unipolar and bipolar depression Psychiatry Res 19 1986 331 333
70. M.K. Sapru, B.S. Rao, and S.M. Channabasavanna Serum dopamine-beta- hydroxylase activity in clinical subtypes of depression Acta Psychiatr Scand 80 1989 474 478
71. D.P. van Kammen, M.E. Kelley, M.W. Gilbertson, J. Gurklis, and D.T. O'Connor CSF dopamine beta-hydroxylase in schizophrenia: associations with premorbid functioning and brain computerized tomography scan measures Am J Psychiatry 151 1994 372 378
72. D.E. Sternberg, D.P. van Kammen, P. Lerner, J.C. Ballenger, S.R. Marder, and R.M. Post CSF dopamine beta-hydroxylase in schizophrenia Arch Gen Psychiatry 40 1983 743 747
73. J.F. Cubells, L.H. Price, B.S. Meyers, G.M. Anderson, C.P. Zabetian, and G.S. Alexopoulos Genotype-controlled analysis of plasma dopamine beta-hydroxylase activity in psychotic unipolar major depression Biol Psychiatry 51 2002 358 364
74. L. Yao, P. Fan, M. Arolfo, Z. Jiang, M.F. Olive, and J. Zablocki Inhibition of aldehyde dehydrogenase-2 suppresses cocaine seeking by generating THP, a cocaine use-dependent inhibitor of dopamine synthesis Nat Med 16 2010 1024 1028
75. W.C. Stanley, B. Li, D.W. Bonhaus, L.G. Johnson, K. Lee, and S. Porter Catecholamine modulatory effects of nepicastat (RS-25560-197), a novel, potent and selective inhibitor of dopamine-beta-hydroxylase Br J Pharmacol 121 1997 1803 1809
76. J.P. Schroeder, D.A. Cooper, J.R. Schank, M.A. Lyle, M. Gaval-Cruz, and Y.E. Ogbonmwan Disulfiram attenuates drug-primed reinstatement of cocaine seeking via inhibition of dopamine beta-hydroxylase Neuropsychopharmacology 35 2010 2440 2449
77. K.A. Cunningham, C.L. Carbone, N.C. Anastasio, T.A. Harper, F.G. Moeller, and D.L. Ware Dopamine hydroxylase inhibitor SYN117 decreases subjective effects of cocaine CPDD 72nd Annual Meeting 2010 Scottsdale, Arizona